DOCUMENT RESOURCES FOR EVERYONE
Documents tagged
Documents USP-Ref-Substances & Authentic Substances

DISTRIBUTOR U.S. Pharmacopeia 12601 Twinbrook Parkway Rockville, MD 20852 Reference Standards Just Released >> Citalopram Hydrobromide Related Compound >> Fluvastatin…

Documents Hyperhidrosis: oxybutynin

Hyperhidrosis: oxybutyninEvidence summary Published: 21 March 2017 www.nice.org.uk/guidance/es10 Key points The content of this evidence summary was up-to-date in March 2017.

Documents Kent and Medway Policy Recommendation and Guidance Committee. Policy Recommendation

Surrey and Sussex Policy Recommendation CommitteePolicy: PR 2014-06: Hyperhidrosis Issue date: May 2014 Review date: May 2017 Recommendation: The Kent and Medway Policy Recommendation

Documents Anticholinergic drugs for overactive bladder

APRES 29-1 for pdf.inddAnticholinergic drugs for overactive bladder William Kuteesa, Fellow in Urogynaecology, and Kate H. Moore, Associate Professor, Pelvic Floor Unit,

Documents Pharmacologic Treatment of Overactive Bladder

FINAL ENVIRONMENTAL SCAN REPORT Conflict of Interest Statement No study members report any affiliations or financial involvement (e.g., employment, consultancies, honoraria,

Documents Efficacy of tolterodine in children with overactive bladder

Original Article / Özgün Aratrma Efficacy of tolterodine in children with overactive bladder Ar aktif mesane tans alan çocuklarda tolterodine kullanmnn etkisi

Documents MANAGEMENT OF URINARY INCONTINENCE AND OVERACTIVE BLADDER

Produced by NHS Greater Glasgow and Clyde Medicines Information Service 1 MANAGEMENT OF URINARY INCONTINENCE AND OVERACTIVE BLADDER No 3, Nov 2015 Produced by NHS Greater

Documents The Effects of Oxybutynin on Urinary Symptoms in Children with Williams-Beuren Syndrome

The Effects of Oxybutynin on Urinary Symptoms in Children with Williams-Beuren SyndromeThe Effects of Oxybutynin on Urinary Symptoms in Children with Williams-Beuren Syndrome